Group 7 Copy 3 Created with Sketch.
News Issue Archive Device Guide Calendar Subscribe Advertising

MENU

Centers

Carotid Coding Dialysis Embolization EVAR HTN Limb Salvage Neurointervention Oncology Radial Regulatory Renal SFA TEVAR Venous

News Current Issue Archive Device Guide Calendar Subscribe Advertising About Contact Privacy Submissions
Carotid Coding Dialysis Embolization EVAR HTN Limb Salvage Neurointervention Oncology Radial Regulatory Renal SFA TEVAR Venous

Advertisement

Advertisement

Search Results

Show Filters

close Created with Sketch.

Refine by Content Type

close Created with Sketch.

Refine by Year

close Created with Sketch.

Advertisement

Sort By:

Relevance Date

Choose Sites to Search:

EVToday EVToday + CIToday

evt | Article | August 2015

An Interview With Ramon Varcoe, MBBS, MS, FRACS

Dr. Varcoe discusses the upcoming VERVE Symposium, his passion for limb salvage, and the importance of good social media practices.

evt | Article | August 2015

Global Perspectives on SFA Treatment: Australia

By Ramon Varcoe, MBBS, MS, FRACS

evt | Article | September 2022

SFA Opportunities and Advancements

By Andrew Holden, MBChB, FRANZCR, EBIR, and Ramon Varcoe, MBBS, MS, FRACS, PhD, MMed(CliniEpi)

evt | News | January 19, 2023

Surmodics’ Sundance Sirolimus-Coated Balloon With Crystalline Drug Release Platform Evaluated in SWING Trial

January 19, 2023—Surmodics, Inc. announced that the differentiated capabilities of its crystalline drug release (CDR) platform for sirolimus-coated balloons (SCBs) were discussed by Professor Ramon Varcoe, MBBS, in his presentation of 12-month data that reinforced key findings from SWING, the first-in-human trial of the company’s Sundance SCB.

Advertisement

Advertisement

evt | News | November 16, 2023

Surmodics Sundance Sirolimus DCB Evaluated in 24-Month SWING Data

November 16, 2023—Surmodics, Inc. announced 24-month data from the SWING trial, a first-in-human study of the company’s Sundance sirolimus drug-coated balloon (DCB).

evt | News | November 17, 2022

Surmodics Sundance Sirolimus DCB Evaluated at 12 Months in SWING Trial

November 17, 2022—Surmodics, Inc. announced the presentation of 12-month data from the SWING trial, a first-in-human study of the company’s Sundance sirolimus drug-coated balloon (DCB).

evt | Article | November 2021

An Interview With Andrew Holden, MBChB, FRANZCR, EBIR

Dr. Holden reflects on the legacy of paclitaxel and lessons learned from the controversy, research priorities for 2022, his philosophy for choosing which projects to accept, and more.

evt | Article | May 2017

CLI: In Focus

By Jos C. van den Berg, MD, PhD, and Jihad A. Mustapha, MD

evt | News | September 3, 2020

Abbott Begins LIFE-BTK Trial to Evaluate Esprit BTK Drug-Eluting Resorbable Scaffold to Treat CLI

September 3, 2020—Abbott announced the start of the LIFE-BTK clinical trial to evaluate the safety and effectiveness of the company’s new Esprit below-the-knee (BTK) everolimus-eluting resorbable scaffold system.

evt | News | October 11, 2022

Surmodics’ Sundance DCB Evaluated in SWING BTK First-in-Human Trial

October 11, 2022—Surmodics, Inc. announced that 6-month data from its SWING first-in-human study of the company’s Sundance sirolimus drug-coated balloon (DCB) were shared at AMP Europe, the European program of the Amputation Prevention Symposium held October 9-11 in Lugano, Switzerland.

evt | Article | September 2025

Real-World Lower Extremity Revascularization Strategies

By Kumar Madassery, MD, FSIR

evt | News | January 14, 2020

New Paclitaxel Meta-Analysis Questions Safety in CLI Population; Concerns Voiced as to Methods

January 15, 2020—In the wake of a year spent scrutinizing the finding of a mortality signal related to paclitaxel-coated balloons and stents in the superficial femoral artery (SFA), a new publication again calls the safety of paclitaxel into question, only this time in the critical limb ischemia (CLI) population.

evt | News | December 13, 2021

DISFORM Classification System Developed for Angioplasty-Induced Femoropopliteal Dissection

December 13, 2021—Based on a three-round, questionnaire-based process using the Delphi consensus methodology, Voûte et al describe the newly proposed DISFORM classification system for angioplasty-induced femoropopliteal dissection.

evt | Article | September 2019

After the Meta-Analysis…

By Sabine Steiner, MD, and Ramon L. Varcoe, MBBS, MS, FRACS, PhD

evt | Article | September 2021

Panel Discussion: Endovascular Therapies for TASC C and D Femoropopliteal Disease

Prof. Ramon L. Varcoe asks Drs. Herbert D. Aronow, Darren B. Schneider, and Sabine Steiner about current evidence for treatment of TASC C and D lesions, their preferred access and approach to advanced disease, if lesion location affects decision-making, and which new therapies hold promise for treating these complex lesions.

evt | Article | February 2014

Ask the Experts

What are your primary solutions for stent graft migration? Have you seen upward migration in the iliacs? How do you manage this?

With Edward Woo, MD; Ross Milner, MD; Ramon L. Varcoe, MD, FRACS; Dittmar Böckler, MD; Ramesh K. Tripathi, MD, FRCS, FRACS; and William D. Jordan, Jr, MD

evt | Article | February 2014

Ask the Experts

What are your primary solutions for stent graft migration? Have you seen upward migration in the iliacs? How do you manage this?

With Edward Woo, MD; Ross Milner, MD; Ramon L. Varcoe, MD, FRACS; Dittmar Böckler, MD; Ramesh K. Tripathi, MD, FRCS, FRACS; and William D. Jordan, Jr, MD

evt | Article | February 2014

Ask the Experts

What are your primary solutions for stent graft migration? Have you seen upward migration in the iliacs? How do you manage this?

With Edward Woo, MD; Ross Milner, MD; Ramon L. Varcoe, MD, FRACS; Dittmar Böckler, MD; Ramesh K. Tripathi, MD, FRCS, FRACS; and William D. Jordan, Jr, MD

evt | Article | September 2019

Panel Discussion: Exploring the Paclitaxel Safety Signal

Experts discuss considerations in trial design, adjudication, and paths forward.

With Marianne Brodmann, MD; William Gray, MD; Peter A. Schneider, MD; Ramon L. Varcoe, MBBS, MS, FRACS, PhD; and Thomas Zeller, MD, PhD

evt | Article | May 2021

The State of Stenting in Below-the-Knee Applications

Assessing stent options and additional technologies for below-the-knee interventions.

By Nedal Katib, MBBCh BAO, MS, FRACS, and Ramon L. Varcoe, MBBS, MS, FRACS, PhD, MMed (ClinEpi)


1
2
3

Advertisement

Advertisement

Carotid Coding Dialysis Embolization EVAR HTN Limb Salvage Neurointervention Oncology Radial Regulatory Renal SFA TEVAR Venous
Centers

Carotid Coding Dialysis Embolization EVAR HTN Limb Salvage Neurointervention Oncology Radial Regulatory Renal SFA TEVAR Venous

News• Current Issue• Archive• Device Guide• Advertising• About Calendar• Contact• Privacy• Submissions• Subscriptions


Endovascular Today (ISSN 1551-1944 print and ISSN 2689-792X online) is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field.



magazine Created with Sketch.

Free Print Subscriptions

Fill 1 Created with Sketch.

Email Newsletter



twitter-icon LinkedIn Created with Sketch. instagram BlueSky-Circle
Cardiac Interventions Today
Group 7 Copy 3 Created with Sketch.
bmc-secondary-mark-color copy Created with Sketch.

© 2026 Bryn Mawr Communications II, LLC.  
All Rights Reserved   •   Privacy Policy

one-trust-button